Research
The lab’s research projects are focused around the innate immune responses to infection in three main areas:
1) The innate immune response to DNA.
DNA is a powerful immunostimulatory agent and our innate immune system has evolved multiple mechanisms to respond to the presence of DNA outside of its normal localisation (inside nuclei and mitochondria). We recently discovered that DNA-PK can activate the IRF-3 dependent production of interferons and cytokines in response to cytoplasmic DNA. We have a Wellcome Trust funded project to extend this analysis to other components of the non-homologous end-joining machinery, and their impact on DNA virus infection.
2) Cell death in innate immunity
The role of cell death in anti-viral defence is well establised. However its function in activating anti-viral immunity is less clear. By analysing signalling pathways that control the switch between pro-inflammatory gene activation and cell death we can probe the consequences of viral-induced cell death in anti-viral defence. We are specifically interested in the role of linear ubiqiutin chains in regulating these processes and in collaboration with Professor Henning Walczak at UCL we are understanding how ubiqutin chains function in pattern recognition receptor signalling and anti-viral defence.
3) Vaccinology
There are many fundamental questions about the development of immunological memory which remain poorly understood. It is clear that the initial detection of a vaccine vector by the innate immune system has long lasting consequences for the development of memory responses. We have developed a panel of mutant viruses which have differential impacts on the development of lymphocyte memory. We have an MRC funded project in collaboration with Professor Geoffrey Smith and Professor David Tscharke to understand the mechanistic basis of how these mutant viruses modulate immunological memory gives us the potential to rationally design improved vaccines.
Collaborations:
Professor Daniel Mansur, University of Santa Caterina, Florianopolis, Brazil
Professor Geoffrey Smith, University of Cambridge, UK
Professor David Tscharke, Australian National Univserity, Canberra, Australia
Professor Henning Walczak, University College London, UK
Professor Steve Jackson, Gurdon Institute, Cambridge, UK
Dr Antonio Rothfuchs, Karolinska Institute, Stockholm, Sweden
Dr Valentyn Oksenych, Norwegian University of Science and Technology,Trondheim, Norway
Publications
Genome-wide analyses reveal a highly conserved Dengue virus envelope peptide which is critical for virus viability and antigenic in humans RC Fleith, FP Lobo, PF dos Santos, MM Rocha, J Bordignon, DM Strottmann, DO Patricio, WR Pavanelli, M Lo Sarzi, CN Dos Santos, BJ Ferguson, DS Mansur Scientific Reports 6, Article number: 36339 |
2016 |
LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammation J Zinngrebe, E Rieser, L Taraborrelli, N Peltzer, T Hartwig, H Ren, I Kovács, C Endres, P Draber, M Darding, S von Karstedt, J Lemke, B Dome, M Bergmann , BJ Ferguson*, H Walczak* J Experimental Medicine (In Press) |
2016 |
Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators RP Sumner, H Ren, BJ Ferguson, GL Smith Vaccine Volume 34, Pages 4827–4834 |
2016 |
The Schistosoma mansoni T2 ribonuclease omega-1 modulates inflammasome-dependent IL-1beta secretion in macrophages BJ Ferguson, S Newland, SE Gibbs, P Tourlomousis, P Fernandes dos Santos, MN Patel, SW Hall, H Walczak, G Schramm, H Haas, DW Dunne, A Cooke, and P Zaccone International Journal for Parasitology Volume 45, Issue 13 Pages 809–813 |
2015 |
Functions of DNA damage machinery in the innate immune response to DNA virus infection BJ Trigg and BJ Ferguson Current Opinion in Virology Volume 15, Pages 56–62 |
2015 |
International Union of Basic and Clinical Pharmacology. XCVI. Pattern Recognition Receptors in Health and Disease CE Bryant, S Orr, BJ Ferguson, MF Symmons, JP Boyle, and TP Monie Pharmacological Reviews vol. 67 no. 2 462-504 |
2015 |
Enhancement of CD8+ T‐cell memory by removal of a vaccinia virus NF‐κB inhibitor H Ren, BJ Ferguson, C Maluquer de Motes, RP Sumner, L Harman, GL Smith Immunology 145 (1), 34-49 |
2015 |
A mechanism for the inhibition of DNA-PK mediated DNA sensing by a virus NE Peters, BJ Ferguson, M Mazzon, AS Fahy, E Krystofinska, R Arribas-Bosacoma, LH Pearl, H Ren, GL Smith PloS Pathogens 9(10): e1003649 |
2013 |
Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity GL Smith, CTO Benfield, CM de Motes, M Mazzon, SWJ Ember, BJ Ferguson, RP Sumner Journal of General Virology, in Press |
2013 |
A mechanism for induction of a hypoxic response by vaccinia virus M Mazzon, NE Peters, C Loenarz, EM Krysztofinska, SWJ Ember, BJ Ferguson, GL Smith Proceedings of the National Academy of Sciences, 110 (30), 12444-12449 |
2013 |
Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence BJ Ferguson, CTO Benfield, H Ren, VH Lee, GL Frazer, P Strnadova, RP Sumner, GL Smith Journal of General Virology, 94 (9), 2070-2081 |
2013 |
Poxvirus Targeting of E3 Ligase β-TrCP by Molecular Mimicry: A Mechanism to Inhibit NF-κB Activation and Promote Immune Evasion and Virulence DS Mansur, CM de Motes, L Unterholzner, RP Sumner, BJ Ferguson, H Ren, P Strnadova, AG Bowie, GL Smith PLoS pathogens 9 (2), e1003183 |
2013 |
Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence SWJ Ember, H Ren, BJ Ferguson, GL Smith Journal of General Virology 93 (Pt 10), 2098-2108 |
2012 |
DNA-PK is a DNA sensor for IRF-3-dependent innate immunity BJ Ferguson, DS Mansur, NE Peters, H Ren, GL Smith eLife Sciences 1 |
2012 |
Mapping the IκB kinase β (IKKβ)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKβ-mediated activation of NF-κB CTO Benfield, DS Mansur, LE McCoy, BJ Ferguson, MW Bahar, AP Oldring, JM Grimes, DI Stuart, SC Graham, GL Smith Journal of Biological Chemistry 286 (23), 20727-20735 |
2011 |